2009, Communication and Drug Pricing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2009

Communication

Drug Pricing

Achieving scale up success under economic uncertainty

European Pharmaceutical Review

SEPTEMBER 14, 2023

Market uncertainty Rising operational costs, stiffening competition, ongoing patent expirations, evolving environmental and social governance requirements and increasing pressure on drug prices mean the industry will have to navigate thoughtfully to be successful amid this complicated mix of financial and strategic risks.

Drug Development

Drug Development Drug Pricing Communication

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.

Documentation

Documentation Hospitals Dosage Drug Pricing

Pharmacist Digest

Achieving scale up success under economic uncertainty

Exforge antitrust settlement caps Novartis’ year of legal disputes

Stay Connected